No evidence for BRAF as a melanoma/nevus susceptibility gene


Jackson, S; Harland, M; Turner, F; Taylor, C; Chambers, PA; Randerson-Moor, J; Swerdlow, AJ; dos Santos Silva, I; Beswick, S; Bishop, DT; Bishop, JAN; (2005) No evidence for BRAF as a melanoma/nevus susceptibility gene. Cancer epidemiology, biomarkers & prevention, 14 (4). pp. 913-8. ISSN 1055-9965 DOI: https://doi.org/10.1158/1055-9965.EPI-04-0568

Full text not available from this repository.

Abstract

Somatic mutations of BRAF have been identified in both melanoma tumors and benign nevi. Germ line mutations in BRAF have not been identified as causal in families predisposed to melanoma. However, a recent study suggested that a BRAF haplotype was associated with risk of sporadic melanoma in men. Polymorphisms or other variants in the BRAF gene may therefore act as candidate low-penetrance genes for nevus/melanoma susceptibility. We hypothesized that promoter variants would be the most likely candidates for determinants of risk. Using denaturing high-pressure liquid chromatography and sequencing, we screened peripheral blood DNA from 184 familial melanoma cases for BRAF promoter variants. We identified a promoter insertion/deletion in linkage disequilibrium with the previously described BRAF polymorphism in intron 11 (rs1639679) reported to be associated with melanoma susceptibility in males. We therefore investigated the contribution of this BRAF polymorphism to melanoma susceptibility in 581 consecutively recruited incident cases, 258 incident cases in a study of late relapse, 673 female general practitioner controls, and the 184 familial cases. We found no statistically significant difference in either genotype or allele frequencies between cases and controls overall or between male and female cases for the BRAF polymorphism in the two incident case series. Our results therefore suggest that the BRAF polymorphism is not significantly associated with melanoma and the promoter insertion/deletion linked with the polymorphism is not a causal variant. In addition, we found that there was no association between the BRAF genotype and mean total number of banal or atypical nevi in either the cases or controls.

Item Type: Article
Keywords: Cutaneous malignant-melanoma, germline mutations, familial, melanoma, polymorphism, variant, cdkn2a, risk, cancer, xrcc3, mc1r
Faculty and Department: Faculty of Epidemiology and Population Health > Dept of Non-Communicable Disease Epidemiology
Research Centre: Centre for Global Non-Communicable Diseases (NCDs)
PubMed ID: 15824163
Web of Science ID: 228351300025
URI: http://researchonline.lshtm.ac.uk/id/eprint/13675

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
291Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item